Breast Cancer Clinical Trials in Baltimore

Showing 761-780 of 805 trials

Ultrasound Based Localization of Lumpectomy Bed in Anatomical Coordinate System

NCT00681304

This is a pilot study. The main purposes for doing the study are to see if there is a relationship between lumpectomy volume and position as measured by USEI and by CT. This is not a study to see if the use of USEI is better than the current method of using CT for daily radiation therapy positioning.

Resected Breast CancerBreast Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins50 participantsStarted Aug 2007

Baltimore, Maryland, United States

COMPLETEDPhase 3< 1 mile

S9630, Medroxyprogesterone in Treating Women With Breast Cancer

NCT00002920

RATIONALE: It is not yet known whether medroxyprogesterone is effective in preventing endometrial disorder in patients with breast cancer who are taking tamoxifen. PURPOSE: Randomized phase III trial to study the effectiveness of medroxyprogesterone in preventing endometrial disorder in postmenopausal women who have ductal carcinoma in situ, lobular carcinoma in situ, Paget's disease of the nipple, stage I breast cancer, or stage II breast cancer and who are taking tamoxifen.

Breast CancerEndometrial Cancer

SWOG Cancer Research Network313 participantsStarted Mar 1997

Mobile, Alabama, United States • Anchorage, Alaska, United States • Phoenix, Arizona, United States +119 more locations

Ultrasound Based Localization of Lumpectomy Bed in Anatomical Coordinate System

S9630, Medroxyprogesterone in Treating Women With Breast Cancer

Breast Cancer Trials in Other Cities

Breast Ultrasound and Mammography in Screening Women at High Risk for Breast Cancer

Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer

Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors

Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers

Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer

A Phase 2 Trial of Standard Chemotherapy, With or Without BSI-201, in Patients With Triple Negative Metastatic Breast Cancer

A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer

APRiCOT-B: Study to Evaluate Apricoxib in Combination With Lapatinib and Capecitabine in the Treatment of HER2/Neu+ Breast Cancer (TP2001-202)

Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast Cancer

Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer

Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for Ductal Carcinoma In Situ or Stage I Breast Cancer

Efficacy and Safety of IPI-504 With Trastuzumab Pretreated, Locally Advanced or Metastatic HER2 Positive Breast Cancer

CNF2024 (BIIB021) HER2- (QD) HER2+ (BIW w/Herceptin) PK/PD Study

Xpress Digital Mammography System Images for Computer Aided Detection Development

Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by Surgery

Combination Study of BMS-754807 and Herceptin® in Patients With Advanced or Metastatic Her-2-positive Breast Cancer

Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98

Other Conditions in Baltimore